Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Potential crawled time : 20:20 save search
Updated Odronextamab Data from Relapsed/Refractory Diffuse Large B-cell Lymphoma Pivotal Trial Showed Deep and Durable Responses and the Potential of ctDNA To Predict Long-term Outcomes
Published: 2023-12-10 (Crawled : 20:20) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
| Email alert
Add to watchlist
trial potential
Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
Published: 2023-12-09 (Crawled : 20:20) - globenewswire.com
IPSC | $3.13 2.62% 2.56% 75K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
cnty-101 trial therapeutics potential
Understanding the Investment Potential of VBOCU – Viscogliosi … – Clayton County Register
Published: 2023-07-23 (Crawled : 20:20) - spacfeed.com
PLTR | $21.64 3.2% 1.76% 34M
|
Technology Services
| Email alert
Add to watchlist
potential
Adverum Biotechnologies Presents Nonclinical Data at the 2023 ARVO Annual Meeting Supporting Potential for Staggered Bilateral Administration of Ixo-vec
Published: 2023-04-23 (Crawled : 20:20) - globenewswire.com
ADVM | News | $11.0 -3.0% -3.47% 310K
|
Health Technology
| Email alert
Add to watchlist
meeting potential
argenx to Present Pivotal ADVANCE Trial Data During ASH Plenary Session Highlighting VYVGART® (efgartigimod alfa-fcab) as Potential New Treatment Modality for Immune Thrombocytopenia
Published: 2022-12-10 (Crawled : 20:20) - globenewswire.com
ARGX | $375.08 1.72% 1.7% 310K
|
Health Technology
| Email alert
Add to watchlist
vyvgart treatment trial potential
Novo Nordisk A/S: Sogroya® data show potential as once-weekly treatment in children living with growth hormone deficiency
Published: 2022-06-12 (Crawled : 20:20) - globenewswire.com
NVO | News | $128.64 2.7% -1.0% 3.5M
|
Health Technology
| Email alert
Add to watchlist
sogroya treatment children potential living growth hormone
Sorrento Announces Publication of a Series of Novel SARS-CoV-2 Main Protease (MPRO) Inhibitors for Potential Treatment of COVID-19 Patients Infected With SARS-CoV-2 Variants Of Concern, Including Omicron
Published: 2021-12-05 (Crawled : 20:20) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: -9.22%
H: 0.0%
C: 0.0%
treatment covid potential sars-cov-2 infections
Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™
Published: 2021-04-10 (Crawled : 20:20) - globenewswire.com
OCX | News | $2.455 -2.19% -0.4% 23K
|
Health Technology
| Email alert
Add to watchlist
potential cancer research
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.